Urinary Creatinine Excretion, Bioelectrical Impedance Analysis, and Clinical Outcomes in Patients with CKD

Abstract

Background and objectives Previous studies in chronic disease states have demonstrated an association between lower urinary creatinine excretion (UCr) and increased mortality, a finding presumed to reflect the effect of low muscle mass on clinical outcomes. Little is known about the relationship between UCr and other measures of body composition in terms of the ability to predict outcomes of interest.Design, setting, participants, & measurements Using data from the Chronic Renal Insufficiency Cohort (CRIC), the relationship between UCr, fat free mass (FFM) as estimated by bioelectrical impedance analysis, and (in a subpopulation) whole-body dual-energy x-ray absorptiometry assessment of appendicular lean mass were characterized. The associations of UCr and FFM with mortality and ESRD were compared using Cox proportional hazards models.Results A total of 3604 CRIC participants (91% of the full CRIC cohort) with both a baseline UCr and FFM measurement were included; of these, 232 had contemporaneous dual-energy x-ray absorptiometry measurements. Participants were recruited between July 2003 and March 2007. UCr and FFM were modestly correlated (rho=0.50; P,0.001), while FFM and appendicular lean mass were highly correlated (rho=0.91; P,0.001). Higher urinary urea nitrogen, black race, younger age, and lower serum cystatin C level were all significantly associated with higher UCr. Over a median (interquartile range) of 4.2 (3.1-5.0) years of follow-up, 336 (9.3%) participants died and 510 (14.2%) reached ESRD. Lower UCr was associated with death and ESRD even after adjustment for FFM (adjusted hazard ratio for death per 1 SD higher level of UCr, 0.63 [95% confidence interval, 0.56 to 0.72]; adjusted hazard ratio for ESRD per 1 SD higher level of UCr, 0.70 [95% confidence interval, 0.63 to 0.75]).Conclusions Among a cohort of individuals with CKD, lower UCr is associated with death and ESRD independent of FFM as assessed by bioelectrical impedance analysis.

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study

“…The rationale for indexing biomarkers to urine creatinine is to account for differences in urine concentration (20). Some studies have suggested that lower urinary creatinine concentration itself may be associated with CKD progression, perhaps because low urine creatinine concentration reflects impaired urine concentrating ability and thus, a dimension of CKD beyond eGFR, such as lower lean body mass (20)(21)(22). Importantly, we did not find an association of 1/urinary Cr with ESRD, suggesting that the indexed results do not simply reflect the association of 1/urinary Cr with the outcome.…”

Urinary Sodium and Potassium Excretion and CKD Progression

“…First, we adjusted age, sex, race, urinary creatinine excretion, and CRIC clinic site in the multivariable models. 36 Second, we added important risk factors for CKD progression in the multivariable models. Furthermore, eGFR at baseline was included in the multivariable models.…”

Clinical Decision Making in a Patient with Stage 5 CKD—Is eGFR Good Enough?

“…Available estimating equations do not have verified accuracy in various non-United States and European white and black racial/ethnic groups (30) or those at extremes of muscle mass or body size or who consume vegetarian or vegan diets. We still have much to learn about relationships between BMI, muscle mass, and creatinine excretion (21,65,66). Furthermore, the serum creatinine concentration on which these formulas are based may be influenced by diet, creatine supplements, and certain medications (i.e., trimethoprim and cimetidine).…”